"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...

India’s Glenmark Pharmaceuticals has received final approval by the US Food and Drug Administration for its fluticasone propionate inhalation aerosol USP, the first generic copy of GSK’s (LSE: GSK) ...

CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S.

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation.

Synopsis: Shares of Glenmark Pharmaceuticals Limited were in focus after its subsidiary Glenmark Specialty SA received approval from the U.S. Food and Drug Administration for a respiratory inhalation ...

Glenmark Pharmaceuticals has gained US FDA approval for its fluticasone propionate inhaler, marking a significant step in strengthening its respiratory offerings.

Glenmark Pharmaceuticals arm, Glenmark Specialty SA has received final approval from the US Food & Drug Administration (FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation.

Glenmark Pharmaceuticals announced that its subsidiary, Glenmark Specialty SA, has received final approval from the U.S. Food and Drug Administration (USFDA) for Fluticasone Propionate Inhalation ...

The drug has been granted a Competitive Generic Therapy designation by the US FDA. Glenmark is recognized as the first ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the 12 Most Promising Small-Cap Stocks According to Wall Street ...